OA11243A - Solubilized sertraline compositions - Google Patents

Solubilized sertraline compositions Download PDF

Info

Publication number: OA11243A
Authority: OA; OAPI
Prior art keywords: composition; matter; agent; sertraline; acid
Prior art date: 1997-07-01

Application number

OA9900301A

Other languages

English (en)

Inventor

Dwayne Thomas Friesen

Ravi Mysore Shanker Sco Herbig

James Blair West

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1999-12-21

Publication date

2003-07-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11243(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-12-21 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2003-07-24 Publication of OA11243A publication Critical patent/OA11243A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Inorganic Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

OA9900301A 1997-07-01 1999-12-21 Solubilized sertraline compositions OA11243A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5141397P	1997-07-01	1997-07-01

Publications (1)

Publication Number	Publication Date
OA11243A true OA11243A (en)	2003-07-24

Family

ID=21971159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA9900301A OA11243A (en)	1997-07-01	1999-12-21	Solubilized sertraline compositions

Country Status (34)

Country	Link
EP (1)	EP0999829A1 (ja)
JP (1)	JP2000514100A (ja)
KR (1)	KR100366373B1 (ja)
CN (1)	CN1261794A (ja)
AP (1)	AP1192A (ja)
AR (3)	AR015917A1 (ja)
AU (1)	AU742535B2 (ja)
BG (1)	BG103918A (ja)
BR (1)	BR9810739A (ja)
CA (1)	CA2290974C (ja)
CO (1)	CO4940495A1 (ja)
DZ (1)	DZ2548A1 (ja)
EA (1)	EA002481B1 (ja)
HN (1)	HN1998000102A (ja)
HR (1)	HRP980377A2 (ja)
HU (1)	HUP0002236A3 (ja)
ID (1)	ID23429A (ja)
IL (1)	IL133076A (ja)
IS (1)	IS5260A (ja)
MA (1)	MA24587A1 (ja)
NO (1)	NO996520L (ja)
OA (1)	OA11243A (ja)
PA (1)	PA8454301A1 (ja)
PE (1)	PE97199A1 (ja)
PL (1)	PL337804A1 (ja)
SK (1)	SK181099A3 (ja)
TN (1)	TNSN98124A1 (ja)
TR (1)	TR199903297T2 (ja)
TW (1)	TW550087B (ja)
UA (1)	UA67741C2 (ja)
UY (1)	UY25071A1 (ja)
WO (1)	WO1999001120A1 (ja)
YU (1)	YU68299A (ja)
ZA (1)	ZA985708B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA006402B1 (ru)	1999-12-23	2005-12-29	Пфайзер Продактс Инк.	Комбинация лекарства и целлюлозного полимера, повышающего концентрацию; способ введения лекарства и водный раствор (варианты)
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
JP2004507502A (ja)	2000-08-30	2004-03-11	ファイザー・プロダクツ・インク	成長ホルモン分泌促進物質のための徐放性製剤
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
WO2008110268A1 (en) *	2007-03-12	2008-09-18	Dsm Ip Assets B.V.	Cosmetic compositions
ME02359B (me)	2009-08-19	2016-06-20	Eisai R&D Man Co Ltd	Farmaceutska kompozicija koja sadrži derivate hinolina
US20120289517A1 (en) *	2009-12-29	2012-11-15	Kowa Co., Ltd.	Solid pharmaceutical composition for oral administration
CN102711763A (zh) *	2009-12-29	2012-10-03	兴和株式会社	口服用医药组合物
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114894736B (zh) *	2022-05-20	2025-03-21	中化地质矿山总局地质研究院	一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
DE69004529T2 (de) *	1989-08-30	1994-02-24	Pfizer	Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Ceased
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active Expired - Fee Related
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/xx active
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
2003
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown

Also Published As

Publication number	Publication date
UA67741C2 (uk)	2004-07-15
HUP0002236A3 (en)	2003-12-29
TR199903297T2 (xx)	2000-07-21
CA2290974A1 (en)	1999-01-14
IL133076A0 (en)	2001-03-19
HRP980377A2 (en)	1999-04-30
EA002481B1 (ru)	2002-06-27
EA199900962A1 (ru)	2000-08-28
SK181099A3 (en)	2000-07-11
BR9810739A (pt)	2000-09-12
BG103918A (en)	2000-07-31
CO4940495A1 (es)	2000-07-24
TNSN98124A1 (fr)	2005-03-15
CN1261794A (zh)	2000-08-02
PL337804A1 (en)	2000-09-11
ID23429A (id)	2000-04-20
NO996520D0 (no)	1999-12-28
MA24587A1 (fr)	1998-12-31
EP0999829A1 (en)	2000-05-17
KR100366373B1 (ko)	2003-01-14
AR040280A2 (es)	2005-03-23
PE97199A1 (es)	1999-10-05
HN1998000102A (es)	1999-01-08
AP1192A (en)	2003-07-23
TW550087B (en)	2003-09-01
AU742535B2 (en)	2002-01-03
IS5260A (is)	1999-11-19
AU7544898A (en)	1999-01-25
CA2290974C (en)	2004-04-27
PA8454301A1 (es)	2000-09-29
WO1999001120A1 (en)	1999-01-14
YU68299A (sh)	2002-06-19
JP2000514100A (ja)	2000-10-24
ZA985708B (en)	2000-01-10
HUP0002236A2 (hu)	2003-08-28
UY25071A1 (es)	2000-12-29
KR20010013365A (ko)	2001-02-26
AR015917A1 (es)	2001-05-30
DZ2548A1 (fr)	2003-02-08
AR040279A2 (es)	2005-03-23
NO996520L (no)	2000-02-29
AP9801280A0 (en)	1998-06-30
IL133076A (en)	2003-12-10

Publication	Publication Date	Title
CA1208559A (en)	1986-07-29	Pharmaceutical mixture
ES2341510T3 (es)	2010-06-21	Microemulsiones como formas farmaceuticas solidas para la administracion oral.
PT1492511E (pt)	2009-04-09	Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
US20070065513A1 (en)	2007-03-22	Stable lansoprazole formulation
BRPI0913822B1 (pt)	2018-12-26	forma farmacêutica oral de liberação controlada para evitar liberação imediata na presença de álcool, e uso da forma farmacêutica
PT1492531E (pt)	2008-12-10	Formulação farmacêutica oral sob a forma de suspensão aquosa de microcápsulas que permite a libertação modificada de amoxicilina
OA11243A (en)	2003-07-24	Solubilized sertraline compositions
ES2852899T3 (es)	2021-09-14	Formulaciones estabilizadas de molindona
US10258583B2 (en)	2019-04-16	Extended release liquid compositions of guanfacine
US11523996B2 (en)	2022-12-13	Extended release liquid compositions of metformin
WO2017182852A1 (en)	2017-10-26	Extended release liquid compositions of guanfacine
HUP0301787A2 (hu)	2003-11-28	A sertralin késleltetett kibocsátású dózisformái
JP2005500307A (ja)	2005-01-06	プラバスタチンを含む安定な徐放性薬剤組成物
US20040208926A1 (en)	2004-10-21	Solubilized sertraline compositions
ES2896150T3 (es)	2022-02-24	Composiciones líquidas de liberación prolongada de guaifenesina
NZ501250A (en)	2003-05-30	Solubilized sertraline compositions
HUP0200711A2 (hu)	2002-07-29	Iható gyógyszerészeti szuszpenzió
CZ464199A3 (cs)	2000-04-12	Solubilizované sertralinové kompozice
AU2922800A (en)	2000-09-21	Pharmaceutical compositions for oral administration comprising a benzamide and at least an absorption promoter
KR20260028023A (ko)	2026-03-03	푸다펜신의 서방형 제형
MXPA99012101A (en)	2000-06-01	Solubilized sertraline compositions
CN121752255A (zh)	2026-03-27	普达芬辛的固体口服制剂
JP2004518679A (ja)	2004-06-24	リポイドビヒクルに分散させたサムパトリラートを含む薬学的組成物
HK1028881A (en)	2001-03-09	Solubilized sertraline compositions
EP3445350A1 (en)	2019-02-27	Extended release liquid compositions of guanfacine